18th Edwaldo Camargo Symposium and 2nd CancerThera Congress host debates on innovative technologies and approaches in cancer in 2025
On April 4 and 5, 2025, the Cyan Convention Center in Itupeva (SP) will host two of the most important
Paper presented by researchers from CEPID CancerThera is awarded as one of the best at ISOLS event in Australia
On October 11, 2024, in Brisbane, Australia, during the 22nd General Meeting of the International Society of Limb Salvage (ISOLS),
Principal researcher at CEPID CancerThera, Carmino A. de Souza participates in FAPESP Week Italy; cooperation and innovation are central themes of the event
The 22nd edition of FAPESP Week, held from October 14 to 15 in Bologna, Italy, brought together around 70 Brazilian
Study Involving Researchers from CEPID CancerThera Shows Therapeutic Potential of Silver Compounds Against Bacterial Infections and Cancers
In recent years, scientists have been searching for new alternatives for the treatment of bacterial infections and cancers, especially through
Principal investigator at CEPID CancerThera, Carmino Antonio de Souza is appointed vice president of FAPESP
The governor of São Paulo, Tarcísio de Freitas, has appointed hematologist Carmino Antonio de Souza as vice president of the
Associated researcher of CEPID CancerThera, Lígia Traldi Macedo is approved in the selection process for Professor of Clinical Oncology at Unicamp
“As soon as the result was announced, a whirlwind of memories came to mind. After 24 years within the university,
Chinese delegation welcomed by CEPID CancerThera researchers to discuss scientific cooperation in cancer treatment
Brazilian and Chinese researchers gathered on September 23 at the Blood Center of the University of Campinas (Unicamp) to discuss
Researchers from CEPID CancerThera, Elba Etchebehere and Allan Santos are elected president and first treasurer of the Brazilian Society of Nuclear Medicine for the 2025-2026 term
On September 14, 2024, during the 38th Brazilian Congress of Nuclear Medicine, held from September 13 to 15 at the
Unicamp and AMAZUL sign memorandum of understanding to establish a commitment in Knowledge Management, Research, Development, and Innovation; CEPID CancerThera will be the first beneficiary
In a ceremony held on September 6, 2024, at the Rectory of the University of Campinas (Unicamp), a memorandum of
Study Conducted by CancerThera Researchers on Palladium(II) and Desoxyaline Complexes Shows Promising Effects on Skin Cancer Cells
In addition to tumor-removal surgery, radiotherapy, chemotherapy, targeted therapy, and immunotherapy are traditional procedures for treating skin cancer patients. Proposing